ANDA 85841, held by Watson Labs. Bethanechol Chloride.
As of Nov 15, 2026, ANDA 85841 (Bethanechol Chloride), held by Watson Labs, was not approved, with 2 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Bethanechol Chloride5MG ยท tablet;oral | Bethanechol Chloride | Discontinued |
| Dec 20, 1988 | Supplement 11Labeling | Approved | None posted |
| Aug 1, 1986 | Supplement 8Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
